Company intelligence
Mitodicure GmbH
Pioneers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) drug development
Biotechnology Research
3 employees
Founded 2022
1 public signals
About Mitodicure GmbH
Mitodicure’s mission is to cure Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), for which there is no effective treatment. With the founders' decades of experience in drug discovery, we are developing a small molecule drug for this frequent and debilitating disease. Patients with Long COVID and Fibromyalgia could also benefit from our medication. Follow us: https://x.com/mitodicure
Verified activity
Signals from Mitodicure GmbH
1 published signal